Literature DB >> 9660967

Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer.

K H Holt1, L E Lim, V Straub, D P Venzke, F Duclos, R D Anderson, B L Davidson, K P Campbell.   

Abstract

Four types of limb-girdle muscular dystrophy (LGMD) are known to be caused by mutations in distinct sarcoglycan genes. The BIO 14.6 hamster is a model for sarcoglycan-deficient LGMD with a deletion in the delta-sarcoglycan (delta-SG) gene. We investigated the function of the sarcoglycan complex and the feasibility of sarcoglycan gene transfer for LGMD using a recombinant delta-SG adenovirus in the BIO 14.6 hamster. We demonstrate extensive long-term expression of delta-sarcoglycan and rescue of the entire sarcoglycan complex, as well as restored stable association of alpha-dystroglycan with the sarcolemma. Importantly, muscle fibers expressing delta-sarcoglycan lack morphological markers of muscular dystrophy and exhibit restored plasma membrane integrity. In summary, the sarcoglycan complex is requisite for the maintenance of sarcolemmal integrity, and primary mutations in individual sarcoglycan components can be corrected in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660967     DOI: 10.1016/s1097-2765(00)80083-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  30 in total

1.  Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters.

Authors:  Masahiko Hoshijima; Takeharu Hayashi; Young E Jeon; Zhenxing Fu; Yusu Gu; Nancy D Dalton; Mark H Ellisman; Xiao Xiao; Frank L Powell; John Ross
Journal:  Circ Heart Fail       Date:  2010-10-29       Impact factor: 8.790

2.  Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalities.

Authors:  Gaynor Miller; Angela K Peter; Erica Espinoza; Jim Heighway; Rachelle H Crosbie
Journal:  J Muscle Res Cell Motil       Date:  2006-07-04       Impact factor: 2.698

3.  Structural and functional analysis of the sarcoglycan-sarcospan subcomplex.

Authors:  Gaynor Miller; Emily L Wang; Karin L Nassar; Angela K Peter; Rachelle H Crosbie
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

Review 4.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

5.  Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments.

Authors:  Carmen Vitiello; Stefania Faraso; Nicolina Cristina Sorrentino; Giovanni Di Salvo; Edoardo Nusco; Gerardo Nigro; Luisa Cutillo; Raffaele Calabrò; Alberto Auricchio; Vincenzo Nigro
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

6.  Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.

Authors:  Tomie Kawada; Mikio Nakazawa; Sakura Nakauchi; Ken Yamazaki; Ryoichi Shimamoto; Masashi Urabe; Jumi Nakata; Chieko Hemmi; Fujiko Masui; Toshiaki Nakajima; Jun-Ichi Suzuki; John Monahan; Hiroshi Sato; Tomoh Masaki; Keiya Ozawa; Teruhiko Toyo-Oka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy.

Authors:  X Xiao; J Li; Y P Tsao; D Dressman; E P Hoffman; J F Watchko
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle.

Authors:  A H Khan; D C Thurmond; C Yang; B P Ceresa; C D Sigmund; J E Pessin
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

Review 9.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

10.  Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.

Authors:  Madeleine Durbeej; Shanna M Sawatzki; Rita Barresi; Kathleen M Schmainda; Valérie Allamand; Daniel E Michele; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.